Effect of home Nasal High-Flow Oxygen Therapy for patients with interstitial pneumonia

Effect of home Nasal High-Flow Oxygen Therapy for patients with interstitial pneumonia - Effect of home Nasal High-Flow Oxygen Therapy for patients with interstitial pneumonia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000052188

Enrollment

Registered

2023-09-14

Start date

2022-09-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial pneumonia

Interventions

Home NHFT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with interstitial pneumonia who are attending respiratory medicine and have been introduced to home oxygen, but whose SpO2 drops to less than 90% on exertion, will be considered. Patients must be able to attend outpatient clinic with no change in home oxygen level for more than 1 month.

Exclusion criteria

Exclusion criteria: Patients who are unable to walk Patients with respiratory disease causing hypoxemia other than interstitial pneumonia Patients who required hospitalization or a change in the amount of home oxygen within one month

Design outcomes

Primary

Measure	Time frame
Questionnaire (Japanese version of K-Bild) scores before and after introduction of NHFT	—

Secondary

Measure	Time frame
Comparison of SpO2 when using HOT and NHFT.	—

Countries

Japan

Contacts

Public ContactYusuke Kurosawa

International University of Health and Welfare Narita Hospital Respiratory medicine

yusuke.kurosawa0813@gmail.com0476-35-5576

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026